CRN’s innovative service model was developed to address a fundamental flaw in clinical trials, which requires patients to be on-site for all protocol visits.
Due to disease state, distance from the site location, travel plans, school, work schedule, etc., traveling to the investigator site can be challenging or inconvenient for many patients of all ages, especially for long-term studies or those requiring frequent patient visits.
To meet study endpoints, sponsors have traditionally had to overenroll, costing valuable time, resources and funds. CRN’s proven model mitigates these issues.
Whether you are conducting early-phase pharmacokinetic studies or phase IV post-marketing safety and survival trials, you can rely on CRN’s expansive service model to reach more than 99% of your study patients and to complete your study with fewer patients and on a more predictable timeline.
